PD-1 Inhibitors Clinical Trials

11 clinical trials for PD-1 Inhibitors across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Electro-Acupuncture in Lung cancER : EALER Study — RECRUITING · NA
• Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer — RECRUITING
• Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC — RECRUITING · NA
• Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC — RECRUITING · NA
• HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416) — COMPLETED
• Combination of SFRT, PD-L1 Inhibitor, and Anti-VEGF in Advanced Hepatocellular Carcinoma — NOT_YET_RECRUITING · NA
• Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Cancer — COMPLETED
• IBI110 Combined With Sintilimab in Second-line Advanced or Metastatic Esophageal Squamous Cell Carcinoma(ESCC) — OTHER · PHASE2
• PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial — OTHER · PHASE2
• Single-center, Prospective Cohort Study of PD-1 Inhibitors on Clinical Outcomes of Carotid Plaques in Tumor Patients — OTHER
• Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer. — OTHER · PHASE3

Refine this search